RVTY News and Press, Revvity Inc.

2026-03-10 18:20:15 ET Revvity, Inc. (RVTY) Barclays 28th Annual Global Healthcare Conference March 10, 2026 10:30 AM EDT... Read the full article on Seeking Alpha For further details see: Revvity, Inc. (RVTY) Presents at Barclays 28th Annual Global Healthcare Conference Tra...

2026-03-03 17:12:16 ET Revvity, Inc. (RVTY) TD Cowen 46th Annual Health Care Conference March 3, 2026 2:30 PM EST... Read the full article on Seeking Alpha For further details see: Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript

2026-03-02 09:57:46 ET Revvity, Inc. (RVTY) 47th Annual Raymond James Institutional Investor Conference March 2, 2026 7:30 AM EST... Read the full article on Seeking Alpha For further details see: Revvity, Inc. (RVTY) Presents at 47th Annual Raymond James Institutional Inves...

2026-02-23 05:00:57 ET More on markets Wax On, Wax Off: The Real Winners Of The Tariff Shock Goodbye Old Tariffs, Hello New Tariffs S&P 500: Best Case Scenario? Another Failed Rally (Technical Analysis) After the Supreme Court's tariff ruling, here's what...

2026-02-19 12:15:50 ET More on Union Pacific, Revvity Union Pacific Corporation (UNP) Presents at Barclays 43rd Annual Industrial Select Conference Transcript Revvity: Close To A Buy, Not Quite There Revvity, Inc. 2025 Q4 - Results - Earnings Call Presentation ...

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences: Raymond James 47 th Annual Institutional Investors Conference Monday, March 2, 2026 7:30 a.m. ET - Max Krakowiak, senior vice president and chief financial officer TD Cowen 46 th...

New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate h...

2026-02-03 13:35:52 ET Thesis Revvity, Inc. ( RVTY ) is a mid-cap U.S.-based company that used to be part of PerkinElmer, but a few years ago it split off to focus on products and services used in drug research and clinical testing. Essentially, Revvity sells lab instrum...

2026-02-03 08:04:40 ET from Evercore ISI issued a price target of $118.00 for RVTY on 2026-02-03 12:55:10. The adjusted price target was set to $118.00. At the time of the announcement, RVTY was trading at $107.09. The overall price target consensus is at $111.00 with hi...

2026-02-03 06:04:34 ET from Barclays issued a price target of $118.00 for RVTY on 2026-02-03 10:28:11. The adjusted price target was set to $118.00. At the time of the announcement, RVTY was trading at $107.09. The overall price target consensus is at $110.50 with high p...